Skip to main content
Medacta Group SA logo

Medacta Group SA — Investor Relations & Filings

Ticker · MOVE ISIN · CH0468525222 LEI · 506700P2PFU3A3DROC14 SW Manufacturing
Open in API
Filings indexed 199 across all filing types
Latest filing 2019-09-03 Earnings Release
Country CH Switzerland
Listing SW MOVE

About Medacta Group SA

https://www.medacta.com/

Medacta Group SA is a medical device company that designs, manufactures, and distributes orthopaedic and neurosurgical products worldwide. Its portfolio focuses on joint replacement, spine surgery, and sports medicine. The company emphasizes innovation in minimally invasive surgical techniques and personalized patient solutions, developed through close collaboration with surgeons. A key component of its business model is the M.O.R.E. Institute, a global medical education platform that provides comprehensive training and support for healthcare professionals. Medacta is recognized for pioneering advanced surgical approaches, such as Kinematic Alignment for total knee replacement, with a focus on improving patient outcomes and healthcare sustainability.

Recent filings

Filing Released Lang Actions
Medacta Group SA: 2019 Half-Year results
Earnings Release Classification · 1% confidence The document is a press release announcing the 2019 Half-Year results for Medacta Group SA. It provides key financial highlights, management commentary, and guidance, but explicitly directs the reader to a separate link to download the actual 'Half-Year Report 2019'. According to the 'Menu vs Meal' rule, since this is an announcement of a report rather than the full report itself, it is classified as an Earnings Release (ER). H1 2019
2019-09-03 English
Medacta Enters U.S. and Australian Sports Medicine Market with Dynamic Lineup of Surgical Solutions
Regulatory Filings Classification · 1% confidence The document is labeled as an "Ad-hoc announcement" released on July 30, 2019, pursuant to Art. 53 KR (likely referring to Swiss Stock Exchange regulations). It announces a specific business event: Medacta entering the U.S. and Australian Sports Medicine market with new product clearances (FDA and TGA). This is a material, non-scheduled corporate event announcement. It is not a full financial report (10-K, IR), an earnings release (ER), a proxy statement (DEF 14A), or a transcript (CT). Since it is a specific, material announcement that doesn't fit the other specific categories (like M&A, Dividend, Director Dealing), it falls best under the general regulatory announcement category, which is RNS (Regulatory Filings), as it is a mandatory disclosure of a significant event.
2019-07-30 English
Medacta opens new U.S. headquarters in Franklin, Tennessee
Regulatory Filings Classification · 1% confidence The document is a press release announcing the official opening of Medacta's new U.S. headquarters in Franklin, Tennessee. It details an investment, job creation, and quotes company executives and the Governor. This type of announcement, which is not a formal financial report (like 10-K, IR, ER) or a specific regulatory filing (like DIRS, DIV, SHA), falls best under the general category for corporate news announcements that don't fit elsewhere, which is Regulatory Filings (RNS) as per the provided definitions, or potentially a general announcement if RNS is reserved strictly for mandatory regulatory submissions. Given the context of EQS Group News Service and the nature of the announcement (corporate expansion/news), RNS serves as the most appropriate catch-all for non-standard, yet important, corporate disclosures that aren't financial results or management changes. It is not a Call Transcript (CT), Earnings Release (ER), or a specific financial report.
2019-07-26 English
Medacta Group SA receives approval in Japan for MyShoulder Placement Guides
Regulatory Filings Classification · 1% confidence The document is an 'Ad-hoc' announcement dated July 24, 2019, released via EQS News Service. It reports that Medacta Group SA received regulatory approval (from PMDA in Japan) for a specific product (MyShoulder Placement Guides). This type of announcement, detailing a regulatory milestone or specific operational update that is material but doesn't fit the standard financial reports (10-K, IR, ER), is best classified as a general Regulatory Filing (RNS) or potentially a Regulatory Approval notice if that were a specific category. Since 'Regulatory Filings' (RNS) is the defined fallback for miscellaneous regulatory announcements that don't fit other specific categories (like DIRS, DIV, CAP, etc.), and this is a specific regulatory approval announcement, RNS is the most appropriate fit among the provided options. It is not a full financial report, earnings release, or management discussion.
2019-07-24 English
Medacta's MySpine MC Wins MedTech Breakthrough Award for Orthopaedics and Surgical Innovation
Regulatory Filings Classification · 1% confidence The document is a press release dated June 5, 2019, announcing that Medacta's MySpine MC platform won a MedTech Breakthrough Award. It details the product, includes quotes from the CEO and a surgeon, and provides boilerplate information about the company. This type of announcement, which is a general news release about an achievement or product recognition rather than a mandatory financial filing (like 10-K, ER, or IR), fits best under the general 'Regulatory Filings' or 'Miscellaneous' category, which is RNS (Regulatory News Service/Regulatory Filings). It is not an Earnings Release (ER), Interim Report (IR), or a specific management/governance document.
2019-06-05 English
Mid Stabilisation Notice - Medacta Group SA
Share Issue/Capital Change Classification · 1% confidence The document is titled "Mid Stabilisation Notice" and details transactions conducted by a Stabilisation Manager (Credit Suisse Securities (Europe) Limited) related to the offer of Medacta Group SA shares, specifically mentioning stabilization activities under Swiss financial market regulations (FMIO). This type of announcement, which reports on market stabilization activities following an offering, does not fit neatly into the primary categories like 10-K, ER, or IR. It is a specific regulatory/market activity announcement. Since it is a specific regulatory announcement that doesn't match the defined categories (like DIRS, DIV, CAP, etc.), the most appropriate fallback category is Regulatory Filings (RNS), as it is a formal notice disseminated via a news service (DGAP/RNS). The document length is short (3974 chars), but it is the primary content, not an announcement *of* another report.
2019-04-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.